PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 176 filers reported holding PRECIGEN INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $150,804 | -16.5% | 106,200 | -32.4% | 0.00% | – |
| Q2 2023 | $180,550 | -1.8% | 157,000 | -9.5% | 0.00% | – |
| Q1 2023 | $183,804 | -64.6% | 173,400 | -49.3% | 0.00% | -100.0% |
| Q4 2022 | $519,401 | -36.7% | 341,711 | -11.8% | 0.00% | -50.0% |
| Q3 2022 | $821,000 | +39.4% | 387,311 | -12.0% | 0.00% | 0.0% |
| Q2 2022 | $589,000 | -50.2% | 439,911 | -21.5% | 0.00% | -33.3% |
| Q1 2022 | $1,183,000 | +0.2% | 560,611 | +76.2% | 0.00% | 0.0% |
| Q4 2021 | $1,181,000 | -8.4% | 318,211 | +23.1% | 0.00% | 0.0% |
| Q3 2021 | $1,290,000 | -47.8% | 258,511 | -31.8% | 0.00% | -57.1% |
| Q2 2021 | $2,471,000 | -41.3% | 379,011 | -38.0% | 0.01% | -41.7% |
| Q1 2021 | $4,210,000 | +85.4% | 611,011 | +174.5% | 0.01% | +100.0% |
| Q4 2020 | $2,271,000 | +238.5% | 222,611 | +16.2% | 0.01% | +200.0% |
| Q3 2020 | $671,000 | -24.1% | 191,611 | +8.2% | 0.00% | -33.3% |
| Q2 2020 | $884,000 | +178.9% | 177,111 | +89.8% | 0.00% | +200.0% |
| Q1 2020 | $317,000 | – | 93,311 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |